1

Executive Chimeric Therapeutics Jobs (NOW HIRING)

Represent the oncology immune therapeutics strategy and portfolio to executive leadership and ... Deep expertise in immuno-oncology and cell therapy, including experience with chimeric antigen ...

... chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based ... edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration ...

... chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based ... edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration ...

... chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based ... edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration ...

$84K - $115K/yr

... chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based ... edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration ...

next page

Showing results 1-20

Executive Chimeric Therapeutics information

See salary details

$26.5K

$93.6K

$184K

How much do executive chimeric therapeutics jobs pay per year?

As of Jul 29, 2026, the average yearly pay for executive chimeric therapeutics in the United States is $93,552.00, according to ZipRecruiter salary data. Most workers in this role earn between $58,000.00 and $120,500.00 per year, depending on experience, location, and employer.
What cities are hiring for Executive Chimeric Therapeutics jobs? Cities with the most Executive Chimeric Therapeutics job openings:
What are the most commonly searched types of Chimeric Therapeutics jobs? The most popular types of Chimeric Therapeutics jobs are:
What states have the most Executive Chimeric Therapeutics jobs? States with the most job openings for Executive Chimeric Therapeutics jobs include:

Head, Oncology Immune Therapeutics

Novartis Farmacéutica

Cambridge, MA • On-site

$288.40 - $535.60/hr

Other

Medical, Life, Retirement

Posted 14 days ago


Job description

#LI-OnsiteLocation: Cambridge, MA, United States Relocation Support: Yes

Step into a pivotal leadership role at the forefront of oncology innovation, where your work will directly shape the future of cancer treatment. As Head, Oncology Immune Therapeutics, you will define and lead the global research and drug discovery strategy across cutting‑edge modalities including cell and gene therapies, immune cell engager therapies, and next‑generation biologics.

You will partner across a highly collaborative scientific ecosystem to translate bold ideas into breakthrough therapies, driving a high‑impact portfolio from early discovery through development candidate selection. This is a unique opportunity to combine deep scientific expertise with strategic influence, building and leading a world‑class team while delivering meaningful advances for patients worldwide.

Key Responsibilities
  • Define and execute the global immuno‑oncology research and drug discovery strategy across multiple therapeutic modalities
  • Lead end‑to‑end discovery programs from hypothesis through development candidate nomination and regulatory readiness
  • Drive a high‑impact oncology pipeline spanning exploratory research, optimization, and clinical‑enabling activities
  • Provide scientific and strategic leadership across cross‑functional teams to advance oncology immune therapeutic programs
  • Shape and prioritize a competitive research portfolio through data‑driven decision making and resource allocation
  • Partner with senior stakeholders to align strategy across research, development, commercial, and strategic functions
  • Lead external innovation through evaluation and execution of business development and collaboration opportunities
  • Establish and advance new scientific directions in immuno‑oncology, including novel targets and therapeutic approaches
  • Build, lead, and develop a high‑performing global organization with deep expertise in cell therapy and immuno‑oncology
  • Represent the oncology immune therapeutics strategy and portfolio to executive leadership and external scientific communities
Essential Requirements
  • Doctor of Philosophy (PhD) or Medical Doctor (MD) in oncology, immunology, biology or related scientific field
  • Deep expertise in immuno‑oncology and cell therapy, including experience with chimeric antigen receptor T‑cell therapies
  • Proven track record leading end‑to‑end oncology research from discovery through development candidate nomination
  • Extensive experience advancing biologics, cell therapies, or gene therapies to Investigational New Drug enabling stage
  • Demonstrated leadership of large, multidisciplinary scientific teams and development of senior talent
  • Strong scientific credibility with a record of high‑impact publications as senior or corresponding author
  • Strategic mindset with ability to make data‑driven portfolio and investment decisions across complex programs
  • Broad industry knowledge and external network across oncology research, clinical development, and biotechnology landscape
Desirable Requirements
  • Experience leading external scientific collaborations, partnerships, or business development evaluations in oncology therapeutics
  • Track record of shaping enterprise‑wide research strategy and influencing senior decision forums across a global matrix
Compensation and Benefits
  • Salary range: $288,400.00 – $535,600.00 USD per year (actual offer based on skills, experience, and periodic review)
  • Performance‑based cash incentive and eligibility for annual equity awards
  • Comprehensive benefits package including health, life and disability benefits, 401(k) with company contribution and match, and other benefits
  • Generous time‑off package: vacation, personal days, holidays and other leaves
#J-18808-Ljbffr